Multi-objective simultaneous optimization technique based on an artificial neural network in sustained release formulations

Journal of Controlled Release

Volumn 49, Issue 1, 1997, Pages 11-20

  Takahara, Junichi ^a   Takayama, Kozo ^a   Nagai, Tsuneji ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Artificial neural networks; Multi objective simultaneous optimization; Response surface method; Second order polynomial equation; Sustained release tablet

Indexed keywords

HYDROXYPROPYLMETHYLCELLULOSE; MAGNESIUM STEARATE; MICROCRYSTALLINE CELLULOSE; TRAPIDIL;

ARTICLE; ARTIFICIAL NEURAL NETWORK; COMPUTER PROGRAM; DRUG MANUFACTURE; DRUG RELEASE; FACTORIAL ANALYSIS; PRIORITY JOURNAL; SUSTAINED RELEASE FORMULATION; TABLET; TABLET COMPRESSION; TABLET FORMULATION;

EID: 0030760466     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(97)00030-8     Document Type: Article

References (13)

1. K.K. Levison, K. Takayama, K. Isowa, K. Okabe and T. Nagai, Formulation optimization of indomethacin gels containing a combination of three kinds of cyclic monoterpenes as percutaneous penetration enhancers, J. Pharm. Sci. 83 (1994) 1367-1372.
2. O. Shirakura, M. Yamada, M. Hashimoto, S. Ishimaru, K. Takayama and T. Nagai, Particle size design using computer optimization technique, Drug. Dev. Ind. Pharm. 17 (1991) 471-483.
3. A.S. Achanta, J.G. Kowalski and C.T. Rhodes, Artificial neural networks: implications for pharmaceutical sciences, Drug. Dev. Ind. Pharm. 21 (1995) 119-155.
4. J.N. Weinstein, K.W. Kohn, M.R. Grever, V.N. Viswanadhan, L.V. Rubinstein, A.P. Monks, D.A. Scudiero, L. Welch, A.D. Koutsoukos, A.J. Chiausa and K.D. Paull, Neural computing in cancer drug development: predicting mechanism of action, Science 258 (1992) 447-451.
5. A.S. Hussain, X. Yu and R.D. Johnson, Application of neural computing in pharmaceutical product development, Pharm. Res. 8 (1995) 1248-1252.
6. B.K. Jha, S.S. Tambe and B.D. Kulkarni, Estimating diffusion coefficients of a micellar system using an artificial neural network, J. Colloid Interfac. Sci. 170 (1995) 392-398.
7. J.V.S. Gobburu and W.H. Shelver, Quantitative structure: pharmacokinetic relationship (QSPR) of beta blockers derived using neural networks, J. Pharm. Sci. 84 (1995) 862-865.
8. B.P. Smith and M.E. Brier, Statistical approach to neural network model building for gentamicin peak predictions, J. Pharm. Sci. 85 (1996) 65-69.
9. A.S. Hussain, R.D. Johnson, N.N. Vachharajani and W.A. Ritschel, Feasibility of developing a neural network for prediction of human pharmacokinetic parameters from animal data, Pharm. Res. 10 (1993) 466-469.
10. E. Brier, J.M. Zurada and G.R. Aronoff, Neural network predicted peak and trough gentamicin concentrations, Pharm. Res. 12 (1995) 406-412.
11. I. Khuri and M. Conlon, Simultaneous optimization of multiple responses represented by polynomial regression functions, Technometrics 23 (1981) 363-375.
12. H. Murase, S. Koyama and R. Ishida, Kalman Neuro Computing, Morikita-shuppan (in Japanese), Tokyo, 1994.
13. I. Ford, M.H. Rubinstein, F. McCaul, J.E. Hogan and P.J. Edgar. Importance of drug type, tablet shape and added diluents on drug release kinetics from hydroxypropylmethylcellulose matrix tablets, Int. J. Pharm. 40 (1987) 223-234.